Format

Send to

Choose Destination
Drug Resist Updat. 2014 Oct-Dec;17(4-6):105-23. doi: 10.1016/j.drup.2014.10.001. Epub 2014 Oct 6.

On the spread and control of MDR-TB epidemics: an examination of trends in anti-tuberculosis drug resistance surveillance data.

Author information

1
Brigham and Women's Hospital, Division of Global Health Equity, Boston, MA 02115, USA; Harvard School of Public Health, Department of Epidemiology, Boston, MA 02115, USA. Electronic address: theodore.cohen@yale.edu.
2
Brigham and Women's Hospital, Division of Global Health Equity, Boston, MA 02115, USA; Harvard Medical School, Boston, MA 02115, USA.
3
Brigham and Women's Hospital, Division of Global Health Equity, Boston, MA 02115, USA; Harvard Medical School, Department of Global Health and Social Medicine, Boston, MA 02115, USA.
4
Harvard Medical School, Boston, MA 02115, USA.
5
Global TB Programme, TB Monitoring and Evaluation, World Health Organization, Geneva, Switzerland.

Abstract

BACKGROUND:

Multidrug resistant tuberculosis (MDR-TB) poses serious challenges for tuberculosis control in many settings, but trends of MDR-TB have been difficult to measure.

METHODS:

We analyzed surveillance and population-representative survey data collected worldwide by the World Health Organization between 1993 and 2012. We examined setting-specific patterns associated with linear trends in the estimated per capita rate of MDR-TB among new notified TB cases to generate hypotheses about factors associated with trends in the transmission of highly drug resistant tuberculosis.

RESULTS:

59 countries and 39 sub-national settings had at least three years of data, but less than 10% of the population in the WHO-designated 27-high MDR-TB burden settings were in areas with sufficient data to track trends. Among settings in which the majority of MDR-TB was autochthonous, we found 10 settings with statistically significant linear trends in per capita rates of MDR-TB among new notified TB cases. Five of these settings had declining trends (Estonia, Latvia, Macao, Hong Kong, and Portugal) ranging from decreases of 3% to 14% annually, while five had increasing trends (four individual oblasts of the Russian Federation and Botswana) ranging from 14% to 20% annually. In unadjusted analysis, better surveillance indicators and higher GDP per capita were associated with declining MDR-TB, while a higher existing absolute burden of MDR-TB was associated with an increasing trend.

CONCLUSIONS:

Only a small fraction of countries in which the burden of MDR-TB is concentrated currently have sufficient surveillance data to estimate trends in drug-resistant TB. Where trend analysis was possible, smaller absolute burdens of MDR-TB and more robust surveillance systems were associated with declining per capita rates of MDR-TB among new notified cases.

KEYWORDS:

Antibiotic resistance; MDR; Multidrug resistance; Surveillance; Trend; Tuberculosis

PMID:
25458783
PMCID:
PMC4358299
DOI:
10.1016/j.drup.2014.10.001
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center